Smørum, Denmark

Marcus Sakari Kauppinnen

USPTO Granted Patents = 6 

Average Co-Inventor Count = 4.8

ph-index = 3

Forward Citations = 12(Granted Patents)


Location History:

  • Smørum, DK (2011 - 2012)
  • Smorum, DK (2012 - 2014)

Company Filing History:


Years Active: 2011-2014

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Marcus Sakari Kauppinnen: Innovator in Endoglucanase Technology

Introduction

Marcus Sakari Kauppinnen is a notable inventor based in Smørum, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides with endoglucanase activity. With a total of 6 patents to his name, Kauppinnen's work has advanced the understanding and application of these important biological molecules.

Latest Patents

Kauppinnen's latest patents focus on isolated polypeptides that exhibit endoglucanase activity. These patents also include isolated polynucleotides that encode these polypeptides. The inventions encompass nucleic acid constructs, vectors, and host cells that incorporate the polynucleotides, along with methods for producing and utilizing the polypeptides. This innovative work has the potential to impact various industries, including agriculture and biofuels.

Career Highlights

Throughout his career, Kauppinnen has worked with prominent companies in the biotechnology sector, including Novozymes, Inc. and Novozymes A/S. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research and development.

Collaborations

Some of Kauppinnen's notable coworkers include Paul Vincent Harris and Elena Vlasenko. Their collaborative efforts have further enriched the research environment and fostered innovation in the projects they have undertaken together.

Conclusion

Marcus Sakari Kauppinnen is a distinguished inventor whose work in endoglucanase technology has made a significant impact in biotechnology. His contributions through patents and collaborations continue to advance the field and inspire future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…